Check Out What Whales Are Doing With VKTX
Portfolio Pulse from Benzinga Insights
Whales have shown a bearish stance on Viking Therapeutics (NASDAQ:VKTX), with options trading indicating a split sentiment between bullish and bearish. Significant options trades have been detected, with a focus on a price band between $12.0 and $90.0. The company specializes in biopharmaceutical development for metabolic and endocrine disorders. Currently, VKTX's stock is down by -2.03%, trading at $70.5, and may be overbought according to RSI readings. Professional analysts have set an average price target of $90.2 for VKTX.
March 14, 2024 | 2:31 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Viking Therapeutics has seen significant whale activity, with a bearish stance overall but mixed sentiment in options trading. Analysts have a positive outlook with an average price target of $90.2.
The mixed sentiment in options trading, combined with the current stock price decrease and analyst ratings, suggests a neutral short-term impact. The bearish stance by whales could pressure the stock, but analyst optimism and the specific bullish options trades provide a counterbalance.
CONFIDENCE 80
IMPORTANCE 90
RELEVANCE 100